摘要
目的:了解长江流域6城市2006—2008年选择性5-羟色胺再摄取抑制剂类(SSRI)抗抑郁药应用状况及变化趋势。方法:采用限定日剂量为指标,对长江流域6城市157家医院2006—2008年临床应用的抗抑郁药的数据资料进行统计分析,对用药金额和用药频度(DDDs)进行排序。结果:城市抗抑郁药的总用药金额逐年增长,在2008年和2007年分别较上一年增长了23.20%和21.13%,总DDDs在2008年和2007年分别较上一年增长了19.96%和21.43%。帕罗西汀、氟西汀、舍曲林始终位于市场前列。结论:SSRI类抗抑郁药用量增幅明显,新型抗抑郁药如艾斯西酞普兰等市场前景广阔。
OBJECTIVE: To probe into the status quo and tendency of the utilization of SSRI antidepressants in 6 cities along Yangtze River valley during the period 2006-2008.METHODS: The SSRI antidepressants used in 157 hospitals in 6 cities along Yangtze River valley during the period 2006-2008 were analyzed statistically with regard to the order in consumption sum and DDDs by using defined daily dose as index.RESULTS: The total consumption sum of the antidepressants in the 6 cities increased year on year,an increase of 23.20% in 2008 and 21.13% in 2007 over the previous year,and the total DDDs increased by 19.96% in 2008 and 21.43% in 2007,respectively over the previous year.Paroxetine,Fluoxetine and Sertraline took the lead in consumption all the time.CONCLUSION: The consumption amount of antidepressants increased significantly and the market of the new antidepressants such as Escit-alopram is promising.
出处
《中国医院用药评价与分析》
2011年第4期322-324,共3页
Evaluation and Analysis of Drug-use in Hospitals of China